Engineered immune cells target broad range of pediatric solid tumors in mice

In mouse studies, a Stanford-led team has developed an engineered immune cell that eliminates several types of childhood tumors. The innovation may help patients with relapsed or metastatic disease.

Read more: http://med.stanford.edu/news/all-news/2019/01/engineered-immune-cells-target-broad-range-of-pediatric-tumors.html